1. Home
  2. IFRX vs FATBP Comparison

IFRX vs FATBP Comparison

Compare IFRX & FATBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$1.07

Market Cap

86.0M

Sector

Health Care

ML Signal

HOLD

Logo FAT Brands Inc. 8.25% Series B Cumulative Preferred Stock

FATBP

FAT Brands Inc. 8.25% Series B Cumulative Preferred Stock

HOLD

Current Price

$1.06

Market Cap

0.0

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFRX
FATBP
Founded
2007
N/A
Country
Germany
United States
Employees
N/A
8845
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
86.0M
N/A
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
IFRX
FATBP
Price
$1.07
$1.06
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
909.6K
N/A
Earning Date
11-10-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$73,729.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,075.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
N/A
52 Week High
$2.77
N/A

Technical Indicators

Market Signals
Indicator
IFRX
FATBP
Relative Strength Index (RSI) 42.44 29.20
Support Level $1.00 $0.91
Resistance Level $1.12 $1.33
Average True Range (ATR) 0.09 0.12
MACD -0.01 0.02
Stochastic Oscillator 36.09 46.37

Price Performance

Historical Comparison
IFRX
FATBP

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

About FATBP FAT Brands Inc. 8.25% Series B Cumulative Preferred Stock

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: